全文获取类型
收费全文 | 4783189篇 |
免费 | 392300篇 |
国内免费 | 15880篇 |
专业分类
耳鼻咽喉 | 67199篇 |
儿科学 | 153397篇 |
妇产科学 | 129725篇 |
基础医学 | 721467篇 |
口腔科学 | 136128篇 |
临床医学 | 433440篇 |
内科学 | 869201篇 |
皮肤病学 | 115383篇 |
神经病学 | 402385篇 |
特种医学 | 189939篇 |
外国民族医学 | 1073篇 |
外科学 | 725427篇 |
综合类 | 145671篇 |
现状与发展 | 24篇 |
一般理论 | 2786篇 |
预防医学 | 398626篇 |
眼科学 | 113651篇 |
药学 | 340738篇 |
19篇 | |
中国医学 | 12915篇 |
肿瘤学 | 232175篇 |
出版年
2021年 | 56253篇 |
2019年 | 58865篇 |
2018年 | 74749篇 |
2017年 | 56957篇 |
2016年 | 63360篇 |
2015年 | 76090篇 |
2014年 | 110693篇 |
2013年 | 176122篇 |
2012年 | 133310篇 |
2011年 | 139406篇 |
2010年 | 127976篇 |
2009年 | 129131篇 |
2008年 | 125555篇 |
2007年 | 134409篇 |
2006年 | 142815篇 |
2005年 | 137597篇 |
2004年 | 138965篇 |
2003年 | 128569篇 |
2002年 | 117615篇 |
2001年 | 179860篇 |
2000年 | 176650篇 |
1999年 | 160454篇 |
1998年 | 74295篇 |
1997年 | 69734篇 |
1996年 | 67663篇 |
1995年 | 63140篇 |
1994年 | 57274篇 |
1993年 | 53221篇 |
1992年 | 120039篇 |
1991年 | 115193篇 |
1990年 | 110792篇 |
1989年 | 107723篇 |
1988年 | 100295篇 |
1987年 | 98324篇 |
1986年 | 93470篇 |
1985年 | 91505篇 |
1984年 | 75666篇 |
1983年 | 66900篇 |
1982年 | 51582篇 |
1981年 | 47686篇 |
1980年 | 44890篇 |
1979年 | 68355篇 |
1978年 | 53608篇 |
1977年 | 46900篇 |
1976年 | 43682篇 |
1975年 | 43681篇 |
1974年 | 49933篇 |
1973年 | 48198篇 |
1972年 | 45224篇 |
1971年 | 41941篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Immunoglobulin light chain amyloidosis (AL) commonly presents with nephrotic range proteinuria, heart failure with preserved ejection fraction, nondiabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea, and should be considered in patients presenting with these symptoms. More importantly, patients being monitored for smoldering multiple myeloma and a monoclonal gammopathy of undetermined significance (MGUS) are at risk for developing AL amyloidosis. MGUS and myeloma patients that have atypical features, including unexplained weight loss; lower extremity edema, early satiety, and dyspnea on exertion should be considered at risk for light chain amyloidosis. Overlooking the diagnosis of light chain amyloidosis leading to therapy delay is common, and it represents an error of diagnostic consideration. Herein we provide a review of established and investigational treatments for patients with AL amyloidosis and provide algorithms for workup and management of these patients.Subject terms: Myeloma, Chemotherapy 相似文献
42.
43.
Melanie A. Krook Julie W. Reeser Gabrielle Ernst Hannah Barker Max Wilberding Gary Li Hui-Zi Chen Sameek Roychowdhury 《British journal of cancer》2021,124(5):880
Fibroblast growth factor receptors (FGFRs) are aberrantly activated through single-nucleotide variants, gene fusions and copy number amplifications in 5–10% of all human cancers, although this frequency increases to 10–30% in urothelial carcinoma and intrahepatic cholangiocarcinoma. We begin this review by highlighting the diversity of FGFR genomic alterations identified in human cancers and the current challenges associated with the development of clinical-grade molecular diagnostic tests to accurately detect these alterations in the tissue and blood of patients. The past decade has seen significant advancements in the development of FGFR-targeted therapies, which include selective, non-selective and covalent small-molecule inhibitors, as well as monoclonal antibodies against the receptors. We describe the expanding landscape of anti-FGFR therapies that are being assessed in early phase and randomised controlled clinical trials, such as erdafitinib and pemigatinib, which are approved by the Food and Drug Administration for the treatment of FGFR3-mutated urothelial carcinoma and FGFR2-fusion cholangiocarcinoma, respectively. However, despite initial sensitivity to FGFR inhibition, acquired drug resistance leading to cancer progression develops in most patients. This phenomenon underscores the need to clearly delineate tumour-intrinsic and tumour-extrinsic mechanisms of resistance to facilitate the development of second-generation FGFR inhibitors and novel treatment strategies beyond progression on targeted therapy.Subject terms: Cancer, Cancer 相似文献
44.
45.
46.
47.
48.
49.
50.
Patrick W. Keeley Mikayla C. Lebo Jordan D. Vieler Jason J. Kim Ace J. St. John Benjamin E. Reese 《The Journal of neuroscience》2021,41(1):103
Amacrine cells of the retina are conspicuously variable in their morphologies, their population demographics, and their ensuing functions. Vesicular glutamate transporter 3 (VGluT3) amacrine cells are a recently characterized type of amacrine cell exhibiting local dendritic autonomy. The present analysis has examined three features of this VGluT3 population, including their density, local distribution, and dendritic spread, to discern the extent to which these are interrelated, using male and female mice. We first demonstrate that Bax-mediated cell death transforms the mosaic of VGluT3 cells from a random distribution into a regular mosaic. We subsequently examine the relationship between cell density and mosaic regularity across recombinant inbred strains of mice, finding that, although both traits vary across the strains, they exhibit minimal covariation. Other genetic determinants must therefore contribute independently to final cell number and to mosaic order. Using a conditional KO approach, we further demonstrate that Bax acts via the bipolar cell population, rather than cell-intrinsically, to control VGluT3 cell number. Finally, we consider the relationship between the dendritic arbors of single VGluT3 cells and the distribution of their homotypic neighbors. Dendritic field area was found to be independent of Voronoi domain area, while dendritic coverage of single cells was not conserved, simply increasing with the size of the dendritic field. Bax-KO retinas exhibited a threefold increase in dendritic coverage. Each cell, however, contributed less dendrites at each depth within the plexus, intermingling their processes with those of neighboring cells to approximate a constant volumetric density, yielding a uniformity in process coverage across the population.SIGNIFICANCE STATEMENT Different types of retinal neuron spread their processes across the surface of the retina to achieve a degree of dendritic coverage that is characteristic of each type. Many of these types achieve a constant coverage by varying their dendritic field area inversely with the local density of like-type neighbors. Here we report a population of retinal amacrine cells that do not develop dendritic arbors in relation to the spatial positioning of such homotypic neighbors; rather, this cell type modulates the extent of its dendritic branching when faced with a variable number of overlapping dendritic fields to approximate a uniformity in dendritic density across the retina. 相似文献